Innoviva (INVA) Consolidated Net Income (2010 - 2026)
Innoviva's Consolidated Net Income was -$83.42 million in Q2 2026, compared with $63.69 million a year earlier.
Powered by 
Analysis
Innoviva (INVA) Consolidated Net Income (2010 - 2026) Analysis & Trends
On a trailing twelve-month basis, Innoviva's Consolidated Net Income was $357.24 million through Jun 30, 2026, up 824.3% year-over-year; for FY2025, it came in at $271.17 million.
- Consolidated Net Income shows a five-year compound annual growth rate of -1.6% (FY2020 to FY2025).
- In earlier years, Consolidated Net Income was $23.39 million in FY2024 (-87.0%), $179.72 million in FY2023 (-18.4%), $220.26 million in FY2022 (-40.3%) and $368.84 million in FY2021 (+25.5%).
- The Q2 2026 figure marks the lowest quarterly Consolidated Net Income in data going back to Q2 2010.
- The best year-over-year quarter for Consolidated Net Income over five years was Q4 2025 (growth of 707.4%); the worst was Q2 2023 (a decline of 94.0%).
- Per Business Quant data, INVA's Consolidated Net Income in the three quarters before Q2 2026 was $186.6 million (Q1 2026), $164.15 million (Q4 2025) and $89.91 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 5.53 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.62 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 3.26 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 2.51 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | -237.00 Mn |
| 10 | Innoviva | 1.49 Bn | -801.70 Mn | 90.62 Mn | -83.42 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -83.42 Mn |
| Mar 31, 2026 | 186.60 Mn |
| Dec 31, 2025 | 164.15 Mn |
| Sep 30, 2025 | 89.91 Mn |
| Jun 30, 2025 | 63.69 Mn |
| Mar 31, 2025 | -46.58 Mn |
| Dec 31, 2024 | 20.33 Mn |
| Sep 30, 2024 | 1.21 Mn |
| Jun 30, 2024 | -34.69 Mn |
| Mar 31, 2024 | 36.53 Mn |
| Sep 30, 2023 | 82.05 Mn |
| Jun 30, 2023 | 1.28 Mn |
| Mar 31, 2023 | 34.87 Mn |
| Dec 31, 2022 | -10.33 Mn |
| Sep 30, 2022 | 229.35 Mn |
| Jun 30, 2022 | 21.37 Mn |
| Mar 31, 2022 | 37.86 Mn |
| Dec 31, 2021 | 45.65 Mn |
| Sep 30, 2021 | 102.65 Mn |
| Jun 30, 2021 | 110.85 Mn |
API Access
Innoviva Consolidated Net Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=INVA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "consolidated-net-income", "ticker": "INVA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=INVA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();